Concert Pharmaceuticals, Inc.
4-hydroxybutyric acid analogs
Last updated:
Abstract:
This invention relates to novel derivatives of 4-hydroxybutyric acid and prodrugs thereof, and pharmaceutically acceptable salts of the foregoing. This invention also provides pharmaceutical compositions comprising a compound of this invention and the use of such compositions in methods of treating narcolepsy, fibromyalgia, other disorders or conditions that are beneficially treated by improving nocturnal sleep or by administering sodium oxybate.
Status:
Grant
Type:
Utility
Filling date:
13 Nov 2017
Issue date:
14 Jan 2020